Aizel Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Months 28 Days
About Aizel Pharma
Aizel Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2024 ( four months 28 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Mahendrakumar Prajapati, Rahul Shukla, and Shrishailam Gatla serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U46497MH2024PTC432647
- Company No.
432647
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Who are the key members and board of directors at Aizel Pharma?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mahendrakumar Prajapati ![]() | Director | 25-Sep-2024 | Current |
Rahul Shukla ![]() | Director | 25-Sep-2024 | Current |
Shrishailam Gatla ![]() | Director | 25-Sep-2024 | Current |
Financial Performance of Aizel Pharma.
Enhance accessibility to Aizel Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Aizel Pharma?
Unlock access to Aizel Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Aizel Pharma?
Unlock and access historical data on people associated with Aizel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Aizel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aizel Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.